Feedback
AUROPHARMA 
Reputation: 642,681 • Jun 23, 2023 5:53 PM
Aurobindo Pharma gains 2% on subsidiary's licence deal for leukemia drug
Eugia Pharma has signed a voluntary sub-licensing agreement with Medicines Patent Pool to make and sell Nilotinib capsules, originally developed by Novartis, for chronic myeloid leukemia in 44 low and middle-income countries
Moneycontrol
Vote
Comment
Share
NSE:AUROPHARMA price when posted: 689.65